MedTrace Logo

PREDICTIVE IMMUNOLOGICAL STUDY OF RECURRENT ABORTIONS AND IMPLANTATION FAILURE

NCT04052438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-08-21

No results posted yet for this study

Summary

The involvement of the immune system in the process of implantation and its modulation as a therapeutic line in these alterations, failure of implantation and repetition abortion are controversial and make it necessary to conduct clinical studies properly led and with a study population chosen by strict criteria in order to better understand the involvement of the different innate and adaptive immune mechanisms in the field of reproductive medicine and especially in clinically expressed failures recurrent implantation failure and recurrent abortions.

Conditions

  • Maternal-Fetal KIR-HLA-C Compatibility

Interventions

DIAGNOSTIC_TEST

HLA-C and KIR determination for patients, couples, oocyte or semen donors, abortive tissue and newborn.

Sponsors & Collaborators

  • IVI Madrid

    lead OTHER

Principal Investigators

  • Diana Alecsandru · IVI Madrid

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-12-31
Completion
2017-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04052438 on ClinicalTrials.gov